Association of the cholesterol-high-density lipoprotein glucose index with metabolic dysfunction-associated fatty liver disease and hepatic steatosis severity: a cross-sectional study based on health examination data

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common metabolic liver disorder closely associated with abnormalities in glucose and lipid metabolism. The cholesterol-high-density lipoprotein glucose index (CHG), a composite marker integrating glucose and lipid metabolism parameters, may reflect the metabolic abnormalities associated with MAFLD. This study aimed to investigate the association between CHG and MAFLD, as well as hepatic steatosis severity. This cross-sectional study included 22,858 adults who underwent routine health examinations at the Health Management Center of the Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine. MAFLD was diagnosed based on abdominal ultrasonography findings and metabolic dysfunction criteria. Logistic regression models, restricted cubic spline analysis, receiver operating characteristic (ROC) curve analysis, and multinomial logistic regression were performed. Participants with MAFLD had significantly higher CHG levels than those without MAFLD (5.44 vs. 5.08, P < 0.001). After adjustment for age, sex, body mass index, alanine aminotransferase, aspartate aminotransferase, creatinine, and uric acid, each standard deviation increase in CHG was associated with higher odds of MAFLD (OR = 2.273, 95% CI: 2.161-2.390, P < 0.001). Restricted cubic spline analysis indicated a nonlinear association between CHG and prevalent MAFLD (P for overall association < 0.001; P for nonlinearity < 0.001). The AUCs for CHG and TyG were 0.801 and 0.829, respectively. CHG levels were also higher across categories of ultrasound-defined hepatic steatosis severity. In this cross-sectional health examination population, CHG was associated with prevalent MAFLD and showed discriminatory ability within the study sample, although its performance was lower than that of TyG. Further validation is required to determine the generalizability and clinical relevance of these findings.

Authors

Institutions

Publication Details

Journal
BMC Gastroenterology
Published
2026-11-13
DOI
https://doi.org/10.1186/s12876-026-05579-7
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of the cholesterol-high-density lipoprotein glucose index with metabolic dysfunction-associated fatty liver disease and hepatic steatosis severity: a cross-sectional study based on health examination data

Xinbei Chen, 庄小金, Lijuan WU, Yan Zheng et al.
7 links
BMC Gastroenterology
Liver Disease Diagnosis and Treatment
article

Association of the cholesterol-high-density lipoprotein glucose index with metabolic dysfunction-associated fatty liver disease and hepatic steatosis severity: a cross-sectional study based on health examination data

Xinbei Chen, 庄小金, Lijuan WU, Yan Zheng, Xuling Ni, Yuling Liang, Lianhua Yin, Yongxiu Lin, Qiaoling Hu, Liming Chen
article en

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common metabolic liver disorder closely associated with abnormalities in glucose and lipid metabolism. The cholesterol-high-density lipoprotein glucose index (CHG), a composite marker integrating glucose and lipid metabolism parameters, may reflect the metabolic abnormalities associated with MAFLD. This study aimed to investigate the association between CHG and MAFLD, as well as hepatic steatosis severity. This cross-sectional study included 22,858 adults who underwent routine health examinations at the Health Management Center of the Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine. MAFLD was diagnosed based on abdominal ultrasonography findings and metabolic dysfunction criteria. Logistic regression models, restricted cubic spline analysis, receiver operating characteristic (ROC) curve analysis, and multinomial logistic regression were performed. Participants with MAFLD had significantly higher CHG levels than those without MAFLD (5.44 vs. 5.08, P < 0.001). After adjustment for age, sex, body mass index, alanine aminotransferase, aspartate aminotransferase, creatinine, and uric acid, each standard deviation increase in CHG was associated with higher odds of MAFLD (OR = 2.273, 95% CI: 2.161-2.390, P < 0.001). Restricted cubic spline analysis indicated a nonlinear association between CHG and prevalent MAFLD (P for overall association < 0.001; P for nonlinearity < 0.001). The AUCs for CHG and TyG were 0.801 and 0.829, respectively. CHG levels were also higher across categories of ultrasound-defined hepatic steatosis severity. In this cross-sectional health examination population, CHG was associated with prevalent MAFLD and showed discriminatory ability within the study sample, although its performance was lower than that of TyG. Further validation is required to determine the generalizability and clinical relevance of these findings.

BMC Gastroenterology
Fujian University of Traditional Chinese Medicine (CN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon